May 10, 2021 Cellectar Reports Financial Results for the First Quarter 2021 and Provides a Corporate Update Learn More
Apr 27, 2021 Cellectar Strengthens Global IP Position with Phospholipid Drug Conjugate Composition of Matter Patent in Eurasia, Australia, and Mexico Learn More
Mar 9, 2021 Cellectar Granted Japanese Composition of Matter Patent for its Phospholipid-Ether Drug Conjugates Learn More